×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Diagnostics Devices Market

ID: MRFR/MED/16247-HCR
128 Pages
Rahul Gotadki
October 2025

India Diagnostics Devices Market Research Report Information By Type (Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics and Others), By Product Type (Instruments/Analysers and Reagents & Kits), By Application (Infectious Disease, Oncology, Hormone, Diabetes, Cardiac and Others), By End User (Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories and Others) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Diagnostics Devices Market Infographic
Purchase Options

India Diagnostics Devices Market Summary

As per MRFR analysis, the India Diagnostics Devices Market was estimated at 2.988 USD Billion in 2024. The India Diagnostics Devices industry is projected to grow from 3.57 in 2025 to 21.21 by 2035, exhibiting a compound annual growth rate (CAGR) of 19.5 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The India Diagnostics Devices Market is poised for substantial growth driven by technological advancements and increasing healthcare access.

  • Technological advancements in diagnostic devices are enhancing accuracy and efficiency in testing procedures.
  • The demand for point-of-care testing is rising, reflecting a shift towards more accessible healthcare solutions.
  • Immunodiagnostics remains the largest segment, while molecular diagnostics is emerging as the fastest-growing segment in the market.
  • Rising prevalence of chronic diseases and government initiatives are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 2.988 (USD Billion)
2035 Market Size 21.21 (USD Billion)
CAGR (2025 - 2035) 19.5%

Major Players

Siemens Healthineers (DE), Roche Diagnostics (CH), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton Dickinson and Company (US), Danaher Corporation (US), Sysmex Corporation (JP), Hologic, Inc. (US), Mylab Discovery Solutions (IN), Trivitron Healthcare (IN)

India Diagnostics Devices Market Trends

The India Diagnostics Devices Market is currently experiencing a transformative phase, characterized by rapid advancements in technology and an increasing emphasis on early disease detection. This evolution is driven by a growing awareness of health issues among the population, alongside a rising demand for efficient and accurate diagnostic solutions. The integration of artificial intelligence and machine learning into diagnostic devices appears to enhance their capabilities, potentially leading to improved patient outcomes. Furthermore, the expansion of healthcare infrastructure in rural and urban areas is likely to facilitate greater access to diagnostic services, thereby broadening the market's reach. In addition, the regulatory environment surrounding medical devices in India is evolving, with authorities striving to streamline approval processes while ensuring safety and efficacy. This shift may encourage innovation and attract investments in the diagnostics sector. As the market continues to grow, collaboration between public and private entities seems essential for fostering research and development. Overall, the India Diagnostics Devices Market is poised for substantial growth, driven by technological advancements, increased healthcare access, and supportive regulatory frameworks.

Technological Advancements

The integration of cutting-edge technologies, such as artificial intelligence and machine learning, is reshaping the landscape of diagnostic devices. These innovations enhance accuracy and efficiency, potentially leading to earlier disease detection and improved patient management.

Increased Healthcare Access

Efforts to expand healthcare infrastructure, particularly in underserved regions, are likely to improve access to diagnostic services. This trend may result in a broader market reach, enabling more individuals to benefit from timely and accurate diagnostics.

Evolving Regulatory Environment

The regulatory framework governing diagnostic devices in India is undergoing significant changes. Streamlined approval processes and a focus on safety and efficacy may foster innovation and attract investment, further propelling market growth.

India Diagnostics Devices Market Drivers

Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases in India is a pivotal driver for the India Diagnostics Devices Market. As lifestyle-related ailments such as diabetes, cardiovascular diseases, and respiratory disorders become more prevalent, the demand for diagnostic devices is expected to surge. According to recent estimates, chronic diseases account for approximately 60% of all deaths in India, necessitating advanced diagnostic solutions. This trend compels healthcare providers to invest in innovative diagnostic technologies, thereby propelling market growth. The India Diagnostics Devices Market is likely to witness a robust expansion as healthcare systems adapt to the growing need for early detection and management of these conditions.

Government Initiatives and Investments

Government initiatives aimed at enhancing healthcare infrastructure significantly influence the India Diagnostics Devices Market. The Indian government has launched various programs to improve healthcare access and affordability, including the Ayushman Bharat scheme, which aims to provide health insurance to millions. Such initiatives are likely to stimulate investments in diagnostic technologies, as healthcare facilities upgrade their capabilities to meet the increased demand. Furthermore, the government's focus on promoting indigenous manufacturing of diagnostic devices could lead to a more competitive market landscape. This strategic direction may enhance the overall growth trajectory of the India Diagnostics Devices Market, fostering innovation and accessibility.

Growing Demand for Point-of-Care Testing

The shift towards point-of-care testing (POCT) is transforming the India Diagnostics Devices Market. POCT offers rapid results and convenience, making it increasingly popular among healthcare providers and patients alike. The market for POCT devices is projected to grow at a compound annual growth rate (CAGR) of over 10% in the coming years, driven by the need for timely diagnosis and treatment. This trend is particularly relevant in rural and underserved areas, where access to traditional laboratory facilities may be limited. As healthcare systems prioritize efficiency and patient-centric care, the India Diagnostics Devices Market is likely to expand in response to this growing demand for POCT solutions.

Technological Innovations in Diagnostic Devices

Technological advancements play a crucial role in shaping the India Diagnostics Devices Market. Innovations such as artificial intelligence, machine learning, and advanced imaging techniques are enhancing the accuracy and efficiency of diagnostic devices. These technologies enable healthcare professionals to make more informed decisions, ultimately improving patient outcomes. The integration of digital health solutions, including telemedicine and remote monitoring, is also gaining traction, further driving the demand for sophisticated diagnostic tools. As the market evolves, the continuous introduction of cutting-edge technologies is expected to propel the growth of the India Diagnostics Devices Market, fostering a more effective healthcare ecosystem.

Increasing Health Awareness and Preventive Healthcare

The rising health consciousness among the Indian population is a significant driver for the India Diagnostics Devices Market. As individuals become more aware of the importance of regular health check-ups and preventive measures, the demand for diagnostic devices is likely to increase. Public health campaigns and educational initiatives are encouraging people to seek early diagnosis and treatment, thereby fostering a culture of preventive healthcare. This shift in mindset is expected to lead to a higher utilization of diagnostic services, which in turn could stimulate growth in the market. The India Diagnostics Devices Market stands to benefit from this trend as healthcare providers adapt to meet the evolving needs of a more health-conscious society.

Market Segment Insights

By Type: Immunodiagnostics (Largest) vs. Molecular Diagnostics (Fastest-Growing)

In the India Diagnostics Devices Market, segment distribution shows Immunodiagnostics holding a significant share, cementing its position as the largest segment. Clinical Chemistry and Haematology follow closely, catering to essential diagnostic requirements across hospitals and laboratories. Tissue Diagnostics and Point of Care Tests are also crucial, but their shares are comparatively smaller, indicating a more niche role within the broader diagnostics landscape. The Others category captures various emerging technologies, though it contributes less to the overall market share compared to the primary segments.

Immunodiagnostics (Dominant) vs. Molecular Diagnostics (Emerging)

Immunodiagnostics stands out as the dominant segment in the India Diagnostics Devices Market, characterized by its extensive application in infectious disease testing, autoimmune disorders, and allergies. Its established technologies and methods contribute to a consistent demand from healthcare providers. Meanwhile, Molecular Diagnostics is emerging rapidly, driven by advancements in genetic testing and personalized medicine. The growth is fueled by increasing awareness of genetic disorders and infectious diseases, leading to a rising acceptance of molecular techniques in routine diagnostics. Both segments exhibit unique advantages, with Immunodiagnostics providing reliability and Molecular Diagnostics pushing the boundaries of diagnostic precision.

By Product Type: Instruments/Analysers (Largest) vs. Reagents & Kits (Fastest-Growing)

In the India Diagnostics Devices Market, the market share distribution indicates that Instruments/Analysers hold the largest share, reflecting their essential role in diagnostic processes. This segment's dominance is attributed to the increasing prevalence of chronic diseases, driving the need for advanced diagnostic equipment across healthcare settings. In contrast, Reagents & Kits are rapidly gaining traction, appealing particularly to laboratories and healthcare providers seeking efficient and effective testing solutions. This division’s market share is bolstered by innovations in reagent technologies and the demand for rapid test kits during health emergencies.

Product Type: Instruments/Analysers (Dominant) vs. Reagents & Kits (Emerging)

Instruments/Analysers are recognized as the dominant force within the India Diagnostics Devices Market, playing a crucial role in providing accurate and timely results across various clinical settings. These devices include a broad range of technologies such as analyzers, imaging devices, and point-of-care instruments that cater to diverse diagnostic needs. On the other hand, Reagents & Kits are emerging as a rapidly developing segment, with their ease of use and quick turnaround times driving their growth. The increasing focus on point-of-care testing and personalized medicine is propelling demand for these products, making them essential components within the diagnostic ecosystem and appealing to both healthcare professionals and patients.

By Application: Infectious Disease (Largest) vs. Diabetes (Fastest-Growing)

In the India Diagnostics Devices Market, the application segment is largely driven by the infectious disease diagnostics, which holds the largest market share. This dominance can be attributed to the heightened focus on disease outbreak management and the rising prevalence of infectious diseases in the region. Other applications, such as oncology and cardiac diagnostics, also play a significant role, but they remain secondary when compared to the infectious disease sector, emphasizing the critical need for advanced diagnostic solutions. In contrast, the diabetes diagnostic market is recognized as the fastest-growing segment. This growth is fueled by increasing diabetes prevalence, changes in lifestyle, and heightened awareness regarding early detection. As more consumers seek effective and timely diabetes management solutions, this segment's innovations in technology and accessibility are key to meeting growing demands, indicating a substantial transformation in the diagnostics landscape.

Infectious Disease (Dominant) vs. Diabetes (Emerging)

The infectious disease diagnostics segment remains dominant in the India Diagnostics Devices Market, characterized by robust technological advancements and substantial investments in disease detection methodologies. This segment encompasses a range of testing devices, specifically tailored to identify pathogens effectively and efficiently. With the rising incidences of infectious diseases, healthcare providers are increasingly adopting comprehensive diagnostic solutions. On the other hand, the diabetes diagnostics sector is emerging rapidly, driven by alarming diabetes statistics nationwide. This segment has seen intensified focus on developing user-friendly devices that facilitate self-monitoring and timely intervention. Both segments exhibit unique market characteristics, with infectious disease diagnostics leading in established practices while diabetes diagnostics captures attention due to its transformative potential.

By End User: Diagnostic Chains (Largest) vs. Hospital Laboratories (Fastest-Growing)

In the India Diagnostics Devices Market, the end-user segment showcases a diverse range of players, with Diagnostic Chains holding a significant share. They have established a robust presence across urban areas, catering to a large volume of diagnostic tests daily. Individual Diagnostic Laboratories and Hospital Laboratories follow, with Individual Laboratories focusing on localized services while Hospital Laboratories integrate diagnostics into patient care. Moreover, the segment of Others, which includes mobile and point-of-care testing facilities, is gaining traction, complementing traditional testing methods.

Diagnostic Chains (Dominant) vs. Hospital Laboratories (Emerging)

Diagnostic Chains are characterized by their extensive network and scale, which enable them to leverage economies of scale and deliver a broad spectrum of services. They are increasingly adopting advanced technologies to enhance service delivery, fostering patient trust and convenience. In contrast, Hospital Laboratories are emerging as vital players in the diagnostics field, integrating diagnostic services with clinical procedures to expedite patient diagnosis and treatment. Their collaboration with healthcare providers enhances operational efficiency, leading to improved patient outcomes and fostering a growing trend towards in-house diagnostic capabilities.

Get more detailed insights about India Diagnostics Devices Market

Regional Insights

North America : Innovation and Technology Leader

The North American diagnostics devices market is driven by technological advancements and a strong regulatory framework. The U.S. holds the largest market share at approximately 60%, followed by Canada at around 20%. The increasing prevalence of chronic diseases and the demand for rapid diagnostic solutions are key growth drivers. Regulatory support from agencies like the FDA further catalyzes innovation in this sector. Leading countries in this region include the United States and Canada, with major players such as Abbott Laboratories and Thermo Fisher Scientific dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships. Companies are focusing on developing advanced diagnostic technologies to meet the growing healthcare demands, ensuring a robust market presence.

Europe : Regulatory Framework and Innovation

The European diagnostics devices market is characterized by stringent regulations and a focus on innovation. Germany and the UK are the largest markets, holding approximately 30% and 25% market shares, respectively. The increasing demand for personalized medicine and point-of-care testing is driving growth. Regulatory bodies like the European Medicines Agency (EMA) play a crucial role in ensuring product safety and efficacy, fostering a conducive environment for market expansion. Key players in this region include Siemens Healthineers and Roche Diagnostics, which are at the forefront of technological advancements. The competitive landscape is marked by a mix of established companies and emerging startups, all striving to innovate and capture market share. The presence of a robust healthcare infrastructure further supports the growth of diagnostic devices in Europe.

Asia-Pacific : Emerging Market with Potential

The Asia-Pacific diagnostics devices market is rapidly expanding, driven by increasing healthcare investments and a growing population. India and China are the largest markets, accounting for approximately 25% and 30% of the market share, respectively. The rising prevalence of diseases and the demand for advanced diagnostic solutions are key growth drivers. Government initiatives aimed at improving healthcare access further catalyze market growth in this region. Leading countries in this region include India, China, and Japan, with significant contributions from local players like Mylab Discovery Solutions and Trivitron Healthcare. The competitive landscape is evolving, with both multinational corporations and local firms vying for market share. The focus on innovation and affordability is crucial for capturing the growing demand in this diverse market.

Middle East and Africa : Growing Demand for Diagnostics

The Middle East and Africa diagnostics devices market is witnessing growth driven by increasing healthcare expenditure and a rising burden of diseases. The UAE and South Africa are the largest markets, holding approximately 20% and 15% market shares, respectively. The demand for advanced diagnostic technologies is on the rise, supported by government initiatives aimed at enhancing healthcare infrastructure and accessibility. Key players in this region include global firms and local companies, with a focus on expanding their presence. The competitive landscape is characterized by partnerships and collaborations aimed at improving product offerings. The growing awareness of healthcare issues is further propelling the demand for diagnostic devices, making this region a significant market for future investments.

India Diagnostics Devices Market Regional Image

Key Players and Competitive Insights

The India Diagnostics Devices Market is currently characterized by a dynamic competitive landscape, driven by technological advancements, increasing healthcare demands, and a growing emphasis on early disease detection. Major players such as Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), and Abbott Laboratories (United States) are strategically positioned to leverage innovation and regional expansion. Siemens Healthineers (Germany) focuses on enhancing its imaging and laboratory diagnostics capabilities, while Roche Diagnostics (Switzerland) emphasizes personalized healthcare solutions. Abbott Laboratories (United States) is actively pursuing partnerships to expand its diagnostic portfolio, thereby shaping a competitive environment that prioritizes technological integration and patient-centric solutions.

Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with a mix of multinational corporations and local players like Mylab Discovery Solutions (India) and Trivitron Healthcare (India) contributing to the market dynamics. These local entities often capitalize on their understanding of regional healthcare needs, which complements the broader strategies of international firms, creating a multifaceted competitive landscape.

In August 2025, Roche Diagnostics (Switzerland) announced the launch of a new point-of-care testing device aimed at improving rapid diagnostics in rural areas. This strategic move is significant as it aligns with the increasing demand for accessible healthcare solutions in underserved regions, potentially enhancing Roche's market share and reinforcing its commitment to innovation in diagnostics.

In September 2025, Abbott Laboratories (United States) expanded its collaboration with local healthcare providers to enhance the distribution of its diagnostic products across India. This initiative is likely to strengthen Abbott's presence in the market, allowing for better penetration and responsiveness to local healthcare demands, which is crucial in a diverse and populous country like India.

In October 2025, Siemens Healthineers (Germany) unveiled a new digital platform designed to integrate artificial intelligence into diagnostic workflows. This development is indicative of a broader trend towards digitalization in the diagnostics sector, suggesting that Siemens is positioning itself at the forefront of technological innovation, which may enhance operational efficiencies and improve patient outcomes.

As of October 2025, current competitive trends in the India Diagnostics Devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing supply chain reliability. Looking ahead, it appears that competitive differentiation will likely evolve from traditional price-based competition to a focus on technological advancements and innovative solutions, underscoring the importance of adaptability in a rapidly changing market.

Key Companies in the India Diagnostics Devices Market market include

Industry Developments

September 2021: Abbott launched its Alinity m Resp-4-Plex molecular diagnostic test, which can detect and differentiate between SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in a single test.

July 2021: Bio-Rad Laboratories launched its QXDx AutoDG ddPCR System, a fully automated droplet digital PCR (ddPCR) system for high-throughput research and clinical laboratories.

Future Outlook

India Diagnostics Devices Market Future Outlook

The India Diagnostics Devices Market is projected to grow at a 19.5% CAGR from 2024 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for early disease detection.

New opportunities lie in:

  • Expansion of telemedicine-integrated diagnostic platforms
  • Development of portable diagnostic devices for rural healthcare
  • Investment in AI-driven diagnostic analytics solutions

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

India Diagnostics Devices Market Type Outlook

  • Immunodiagnostics
  • Clinical Chemistry
  • Tissue Diagnostics
  • Haematology
  • Point of Care Tests
  • Molecular Diagnostics
  • Others

India Diagnostics Devices Market End User Outlook

  • Diagnostic Chains
  • Individual Diagnostic Laboratories
  • Hospital Laboratories
  • Others

India Diagnostics Devices Market Application Outlook

  • Infectious Disease
  • Oncology
  • Hormone
  • Diabetes
  • Cardiac
  • Others

India Diagnostics Devices Market Product Type Outlook

  • Instruments/Analysers
  • Reagents & Kits

Report Scope

MARKET SIZE 20242.988(USD Billion)
MARKET SIZE 20253.57(USD Billion)
MARKET SIZE 203521.21(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)19.5% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesIntegration of artificial intelligence in diagnostic devices enhances accuracy and efficiency in the India Diagnostics Devices Market.
Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the India Diagnostics Devices Market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Leave a Comment

FAQs

What is the current valuation of the India Diagnostics Devices Market in 2024?

The market valuation of the India Diagnostics Devices Market was 2.988 USD Billion in 2024.

What is the projected market size for the India Diagnostics Devices Market by 2035?

The projected market size for the India Diagnostics Devices Market is expected to reach 21.21 USD Billion by 2035.

What is the expected CAGR for the India Diagnostics Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the India Diagnostics Devices Market during the forecast period 2025 - 2035 is 19.5%.

Which segment is projected to have the highest valuation in the India Diagnostics Devices Market by 2035?

The Reagents & Kits segment is projected to reach a valuation of 12.65 USD Billion by 2035.

What are the key applications driving growth in the India Diagnostics Devices Market?

Key applications include Diabetes, Oncology, and Infectious Disease, with projected valuations of 4.5 USD Billion, 4.2 USD Billion, and 3.5 USD Billion respectively by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions